-$0.56 Earnings Per Share Expected for Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) This Quarter
Wall Street analysts forecast that Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX – Get Rating) will report ($0.56) earnings per share (EPS) for the current quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Crinetics Pharmaceuticals’ earnings, with the lowest EPS estimate coming in at ($0.63) and the highest estimate coming in at ($0.44). Crinetics […]